Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2013
10/17/2013US20130274281 Methods of treating metastatic breast cancer with 4-iodo-3-nitrobenzamide and irinotecan
10/17/2013US20130274277 Treatment for discoid lupus
10/17/2013US20130274275 4-phenylamino-quinazolin-6-yl-amides
10/17/2013US20130274274 Substituted pyridopyrimidine compounds and their use as flt3 inhibitors
10/17/2013US20130274272 Methyl/difluorophenyl-methoxy substituted pyridinone-pyridinyl compounds, methyl-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds, and methyl-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds
10/17/2013US20130274271 Methods and compositions for prevention and treatmentof cardiac hypertrophy
10/17/2013US20130274270 Polymorphs of 3-chloro-4[(2r)-2-(4-chlorophenyl)-4-[(1r)-1-(4-cyanophenyl)ethyl]-1-piperazinyl]-benzonitrile, pharmaceutical compositions and method of use comprising said polymorphs, and a process for preparing them
10/17/2013US20130274267 Inhibitors for antiviral use
10/17/2013US20130274263 Tubulin inhibitors
10/17/2013US20130274262 Pharmaceutical compositions of linezolid
10/17/2013US20130274261 Methods for treating pulmonary hypertension
10/17/2013US20130274259 Kinase modulation and indications therefor
10/17/2013US20130274256 Novel inhibitors of bacterial biofilms and related methods
10/17/2013US20130274255 Heterocyclic pyrazole compounds, method for preparing the same and use thereof
10/17/2013US20130274254 Inhibitors of cytochrome p450 (cyp3a4)
10/17/2013US20130274252 Quinazoline derivatives as kinase inhibitors
10/17/2013US20130274251 2-(2-phenylethenyl) 1,3-benzodiazepine compounds useful for the treatment of cancer
10/17/2013US20130274249 Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
10/17/2013US20130274247 Mirtazapine as an Appetite Stimulant for Cats
10/17/2013US20130274246 Therapeutic Treatment for Metabolic Syndrome, Type 2 Diabetes, Obesity, or Prediabetes
10/17/2013US20130274245 Composition For Prevention of Vasoactivity in the Treatment of Blood Loss and Anemia
10/17/2013US20130274243 Chemical Compounds
10/17/2013US20130274242 Substituted pyrimidine compounds and their use as syk inhibitors
10/17/2013US20130274241 Indazolyl triazol derivatives
10/17/2013US20130274239 Poly (adp-ribose) polymerase (parp) inhibitors
10/17/2013US20130274238 Combination Medicaments for Treating Bacterial Infections
10/17/2013US20130274237 Composition including chlorophyll a as an active ingredient for preventing and treating th2-mediated immunological diseases
10/17/2013US20130274236 Fulvestrant compositions and methods of use
10/17/2013US20130274235 Treatment of motor neuron disease
10/17/2013US20130274233 Modulators of hedgehog signaling pathway
10/17/2013US20130274232 Pharmaceutical Compositions
10/17/2013US20130274231 Compositions for use in treatment of dermatological diseases and conditions
10/17/2013US20130274228 Concomitant drug for improving cognitive function
10/17/2013US20130274227 3,5-diaminopyrazole kinase inhibitors
10/17/2013US20130274224 Sterile injectable aqueous formulation used in ophthalmology
10/17/2013US20130274220 Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase
10/17/2013US20130274219 Methods for treating non-small cell lung cancer using 5-azacytidine
10/17/2013US20130274218 Viral polymerase inhibitors
10/17/2013US20130274216 Treatment for microbe-induced inflammatory responses in the eye
10/17/2013US20130274215 Pharmaceutical compositions to treat fibrosis
10/17/2013US20130274214 Method for treating blepharitis
10/17/2013US20130274212 Sesterterpene Compounds and Use Thereof
10/17/2013US20130274203 Anti-ssx-2 t cell receptors and related materials and methods of use
10/17/2013US20130274198 Treating muc1-expressing cancers with combination therapies
10/17/2013US20130274197 Benzodiazepinone compounds useful in the treatment of skin conditions
10/17/2013US20130274191 Methods and compositions for therapeutic modulation of aldosterone levels in heart disease
10/17/2013US20130274184 Er stress relievers in beta cell protection
10/17/2013US20130274180 Pharmaceutical Compositions
10/17/2013US20130274179 Viral polymerase inhibitors
10/17/2013US20130274175 Treatment of disease associated with the use of antibiotics
10/17/2013US20130274174 Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use
10/17/2013US20130273659 Nanoparticles of cerium and amino acids
10/17/2013US20130273651 Differentiated cells suitable for human therapy
10/17/2013US20130273234 Biocompatible Polyacrylate Compositions For Medical Applications
10/17/2013US20130273186 Gamma-polyglutamic acid-based ocular irrigating solutions
10/17/2013US20130273181 Methods and compositions for diagnosing and treating muscle myopathy disorders
10/17/2013US20130273178 Methods and compositions for promoting activity of anti-cancer therapies
10/17/2013US20130273177 Isoflavonoid compositions and methods for the treatment of cancer
10/17/2013US20130273176 Methods and compositions useful for promoting sleep in animals
10/17/2013US20130273172 Topical pharmaceutical compositions containing nanodroplets for the treatment psoriasis
10/17/2013US20130273171 Oral formulation for dexlansoprazole
10/17/2013US20130273168 Solid dosage form comprising proton pump inhibitor and suspension made thereof
10/17/2013US20130273165 Carnitine granulate and methods for its production
10/17/2013US20130273164 Nanotechnology approach for inhalation therapies
10/17/2013US20130273162 Oral Film Containing Opiate Enteric-Release Beads
10/17/2013US20130273158 Extended release compositions of quetiapine
10/17/2013US20130273157 Orally disintegrating tablet
10/17/2013US20130273156 Oral pharmaceutical tablet for controlled release of mesalazine and process for obtaining it
10/17/2013US20130273155 Prebiotic Compositions for use with Probiotics to increase probiotic growth rate and activity
10/17/2013US20130273153 Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans
10/17/2013US20130273151 MicroRNA Fingerprints During Human Megakaryocytopoiesis
10/17/2013US20130273146 Methods for preparation of lipid-encapsulated therapeutic agents
10/17/2013US20130273141 Volatile anesthetic compositions and methods of use
10/17/2013US20130273138 Transdermal formulations of geranylgeranylacetone
10/17/2013US20130273134 Pesticidal ear tag
10/17/2013US20130273119 Transdermal drug administration device
10/17/2013US20130273117 Methods and systems for generating nanoparticles
10/17/2013US20130273115 Injectable filler
10/17/2013US20130273114 Pharmaceutical compositions of immunosuppressants
10/17/2013US20130273096 Therapeutic Sulfated Polysaccharides, Compositions Thereof, and Methods for Treating Patients
10/17/2013US20130273084 Use of a dna expression construct
10/17/2013US20130273078 Synergistic anti-tumor efficacy using alloantigen combination immunotherapy
10/17/2013US20130273065 Therapeutic Compositions For Treatment Of Inflammation Of Ocular And Adnexal Tissues
10/17/2013US20130273061 Combination therapy
10/17/2013US20130273057 Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders
10/17/2013US20130273056 Tyrosine-phosphorylated wbp2, a novel cancer target and biomarker
10/17/2013US20130273035 Methods and Compositions for Reducing Amyloid Beta Levels
10/17/2013US20130273034 Novel compounds and compositions for the inhibition of nampt
10/17/2013US20130273030 Use of inhibitors of bruton's tyrosine kinase (btk)
10/17/2013US20130273019 Compositions for Topical Treatment of Medical Conditions Including Wounds and Inflammation
10/17/2013US20130273017 Methods and products for tissue repair
10/17/2013US20130273009 Methods to mobilize progenitor/stem cells
10/17/2013US20130273005 Methods for treating hcv
10/17/2013US20130273004 Substituted alkylamine derivatives and methods of use
10/17/2013US20130273003 Therapies for Treating Hepatitis C Virus Infection
10/17/2013US20130273001 Immunostimulation by chemically modified rna
10/17/2013US20130272999 Epidermal Growth Factor Composition, A Process Therefor and Its Application
10/17/2013US20130272998 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulations of angiogenesis and anticancer therapy
10/17/2013US20130272997 Synthetic mechanical hemostatic composition, method of making and use thereof
10/17/2013US20130272996 Treatment of multiple sclerosis with laquinimod
1 ... 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 ... 7860